Differential clinical characteristics of prescription of lithium vs. valproate: What do clinicians expect for lithium and valproate?

被引：0
|
作者：
Owashi, T. [1 ]
Tanaka, H. [1 ]
Hida, M. [2 ]
Yokoyama, S. [2 ]
Kumata, T. [1 ,3 ]
Kudo, I. [1 ,2 ]
机构：
[1] Showa Univ, Fujigaoka Hosp, Yokohama, Kanagawa 227, Japan
[2] Showa Univ, No Yokohama Hosp, Yokohama, Kanagawa, Japan
[3] Hiyoshi Hosp, Yokohama, Kanagawa, Japan
来源：
BIPOLAR DISORDERS | 2012年 / 14卷
关键词：
mood stabilizer; lithium; valproate; prescription; bipolar disorder;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 9 条
  • [1] Differential effects of chronic lithium and valproate on brain activation in healthy volunteers
    Bell, EC
    Willson, MC
    Wilman, AH
    Dave, S
    Silverstone, PH
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (06) : 415 - 424
  • [2] Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records
    Hayes, Joseph F.
    Marston, Louise
    Walters, Kate
    Geddes, John R.
    King, Michael
    Osborn, David P. J.
    WORLD PSYCHIATRY, 2016, 15 (01) : 53 - 58
  • [3] The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007-A prescription database study
    Bramness, Jorgen G.
    Groholt, Berit
    Engeland, Anders
    Furu, Kari
    JOURNAL OF AFFECTIVE DISORDERS, 2009, 117 (03) : 208 - 211
  • [4] Effects of Mood Stabilizers on Psychomotor Functioning: Patients on Lithium or Valproate Monotherapy vs. Drug-Free Patients
    Atagun, Murat I.
    Balaban, Ozlem D.
    Yesilbas, Dilek
    Yesilyurt, Sema
    Keskinkilic, Cahit
    Evren, Cuneyt
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 137S - 137S
  • [5] Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors
    Crapanzano, Calogero
    Casolaro, Ilaria
    Amendola, Chiara
    Damiani, Stefano
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (03) : 403 - 414
  • [6] Lurasidone for Prevention of Recurrence in Patients With Bipolar I Disorder: Comparison of Adjunctive Therapy With Lithium Vs. Valproate
    Nemeroff, Charles
    Pikalov, Andrei
    Tsai, Joyce
    Mao, Yongcai
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S169 - S169
  • [7] Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression
    Niciu, Mark J.
    Xu, Annie J.
    Lundin, Nancy B.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Richards, Erica M.
    Voort, Jennifer L. Vande
    Ballard, Elizabeth D.
    Brutsche, Nancy E.
    Machado-Vieira, Rodrigo
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 130S - 130S
  • [8] Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial
    Kang, Mehar G.
    Qian, Hong
    Keramatian, Kamyar
    Chakrabarty, Trisha
    Saraf, Gayatri
    Lam, Raymond W.
    Wong, Hubert
    Yatham, Lakshmi N.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2020, 54 (03): : 298 - 307
  • [9] Factors influencing lithium versus valproate prescription preference in the maintenance treatment of bipolar patients: a report from the Italian Early Career Psychiatrists (SOPSI-GG)
    Buoli, Massimiliano
    Gattoni, Eleonora
    Collantoni, Enrico
    Monteleone, Alessio Maria
    Solmi, Marco
    Longo, Luisa
    Ribolsi, Michele
    Santambrogio, Jacopo
    Bersani, Francesco Saverio
    Aguglia, Andrea
    Serafini, Gianluca
    Signorelli, Maria Salvina
    Dell'Osso, Bernardo
    Luciano, Mario
    Galderisi, Silvana
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2021, 25 (01) : 82 - 89
1